drugset / Trial / NCT01053910
Ramipril 10 mg/Day Prevention
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective is to investigate the safety of ramipril 10 mg/day used in prevention of cardiovascular events in high-risk patients, including the criteria of the HOPE study.
Timeline
- Start
- 2003-10
- Primary completion
- 2005-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramipril | Small molecule | 10 mg | — |